Mitsubishi Tanabe Pharma issues its news to provide stakeholders with the latest information related to the Company. Information on products or drug candidates may be included, but is intended to provide for the media, etc. It is not intended for promotion, advertising or medical advice. Information is current as of the date of issue of the individual news. Please be advised that information may be outdated after that point.
Information Mitsubishi Chemical Group ― Notice of Award for the Arbitration Filed against Mitsubishi Tanabe Pharma Corporation, a Consolidated Subsidiary
February 14, 2023
The parent company of Mitsubishi Tanabe Pharma Corporation (Head Office: Osaka, Japan; Representative Director: Hiroaki Ueno), Mitsubishi Chemical Group Corporation (Head office: Chiyoda-ku, Tokyo; President: Jean-Marc Gilson) made the following announcement today.
Notice of Award for the Arbitration Filed against Mitsubishi Tanabe Pharma Corporation, a Consolidated Subsidiary
URL:https://www.mcgc.com/english/news_release/pdf/01491/01727.pdf